Source-grounded facts extracted from Hanover Bancorp, Inc. /MD's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Hanover Bancorp, Inc. /MD shareholders approved Ratification of Crowe LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-28 meeting.
“The appointment of Crowe LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was ratified by the shareholders by the following vote:”
Hanover Bancorp, Inc. /MD shareholders approved The Hanover Bancorp, Inc. 2026 Equity Incentive Plan at the 2026-05-28 meeting.
“The Hanover Bancorp, Inc. 2026 Equity Incentive Plan was approved by the shareholders by the following vote:”
Hanover Bancorp, Inc. /MD shareholders approved Election of directors each for a three-year term at the 2026-05-28 meeting.
“The following individuals were elected as directors, each for a three-year term, by the following vote:”
Hanover Bancorp, Inc. /MD reported the quarter ended March 31, 2026 results: net income $1.9 million, EPS $0.25 per diluted share.
“Margin Expansion and Declares $0.10 Quarterly Cash Dividend First Quarter Performance Highlights ● Net Income: Net income for the quarter ended March 31, 2026 totaled $1.9 million or $0.25 per diluted share (including Series A preferred shares). Adjusted (non-GAAP) net income (excluding severance expenses) was $4.0 million or $0.54 per diluted share for”
Hanover Bancorp, Inc. /MD incurred senior notes of $35.0 million with certain qualified institutional buyers and accredited investors at 7.25% Fixed-to-Floating Rate maturing March 15, 2036.
“the Company issued and sold $35.0 million in aggregate principal amount of its 7.25% Fixed-to-Floating Rate Subordinated Notes due 2036”
Hanover Bancorp, Inc. /MD entered into Subordinated Note Purchase Agreements with certain qualified institutional buyers and accredited investors valued at $35.0 million (effective 2026-03-12).
“On March 12, 2026, Hanover Bancorp, Inc. (the “Company”) entered into Subordinated Note Purchase Agreements (collectively, the “Purchase Agreements”) with certain qualified institutional buyers and accredited investors (collectively, the “Purchasers”) pursuant to which the Company issued and sold $35.0 million in aggregate principal amount of its 7.25% Fixed-to-Floating Rate Subordinated Notes due 2036 (the “Notes”).”
Hanover Bancorp, Inc. /MD: Adoption of Maryland Bylaws governing surviving corporation on effective date (effective 2025-06-25).
“the rights of the registrant’s stockholders began to be governed by statutory corporate laws of Maryland, governed by the MGCL, the Articles of Incorporation and the Maryland Bylaws, adopted pursuant to the Merger Agreement.”
Hanover Bancorp, Inc. /MD: Reincorporation merger from New York to Maryland, adopting new Articles of Incorporation and Bylaws under MGCL as of the effective date (effective 2025-06-25).
“Effective as of June 25, 2025 (the “Effective Day”), Parent merged with and into the Company, with the Company being the surviving corporation and successor in interest to Parent.”
Hanover Bancorp, Inc. /MD underwent a change of control (closed 2025-06-25).
“On June 25, 2025, Hanover Bancorp, Inc., a New York corporation (“Parent”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Hanover Bancorp, Inc., a Maryland corporation and Parent’s wholly owned subsidiary (the “Surviving Corporation” or the “Company”), pursuant to which, on the same date, Parent merged with and into the Surviving Corporation (the “Reincorporation Merger”).”
Michael Thaden was appointed as director at Hanover Bancorp, Inc. /MD.
“appointed Michael Thaden as a director of the Company, effective immediately.”
Hanover Bancorp, Inc. /MD: Increased authorized shares of Series A Convertible Perpetual Preferred Stock from 150,000 to 450,000 (effective 2024-04-25).
“the Company agreed to: (i) file with the Secretary of State of the State of New York a Certificate of Amendment to the Company’s Certificate of Incorporation (the “Amendment”) increasing the number of authorized shares of the Company’s Series A Convertible Perpetual Preferred Stock (“Series A Preferred Stock”) from 150,000, par value $0.01 per share, to 450,000, par value $0.01 per share”
Hanover Bancorp, Inc. /MD entered into Exchange Agreement with Castle Creek Capital Partners VIII, L.P. (effective 2024-04-25).
“On April 25, 2024, Hanover Bancorp, Inc. (the “Company”) entered into an Exchange Agreement (the “Exchange Agreement”) with Castle Creek Capital Partners VIII, L.P. (“Castle Creek”).”
Hanover Bancorp, Inc. /MD reported the quarter ended March 31, 2024 results: net income $4.1 million, EPS $0.55 per diluted share.
“Net income for the quarter ended March 31, 2024 totaled $4.1 million or $0.55 per diluted share (including Series A preferred shares)”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.